Cadence Bank Novo Nordisk A S Transaction History

Cadence Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$122.71 - $146.91 $82,951 - $99,311	-676 Reduced 26.32%	1,892 $270,000
Q4 2023 Feb 13, 2024	SELL	$87.78 - $105.45 $53,896 - $64,746	-614 Reduced 19.3%	2,568 $265,000
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $144,685 - $317,468	1,591 Added 100.0%	3,182 $289,000
Q1 2023 May 12, 2023	BUY	$132.34 - $159.14 $210,552 - $253,191	1,591 New	1,591 $253,000

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $246B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Cadence Bank, based on Form 13F filings with the SEC.

Stay updated on Cadence Bank with notifications on news.